Doctor Knows Best Act of 2025
- Bill Number
- H.R. 639
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-01-22: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Last Updated
- 2025-05-12T18:20:49Z
AI-Generated Summary
Purpose
The "Doctor Knows Best Act of 2025" (H.R. 639) aims to eliminate barriers in health insurance and federal health programs that delay access to medical treatments. It seeks to prevent insurers and government programs from requiring pre-approvals or reviews that could interfere with doctors' decisions on patient care for covered services.
Key Provisions
- Prohibition for Private Insurers: Amends the Public Health Service Act to ban group health plans (employer-sponsored insurance) and health insurance issuers (companies selling plans) from using:
- Prior authorization requirements: Rules needing pre-approval from the insurer before covering a treatment or service.
- Utilization management techniques: Methods to control costs and usage, such as step therapy (requiring patients to try cheaper treatments first) or fail-first protocols (mandating less expensive options before approving others).
- Medical necessity reviews: Assessments to determine if a treatment is essential for the patient's condition.
These bans apply to any item or service covered under the plan.
- Prohibition for Federal Health Programs: Starting January 1, 2026, federal health care programs (like Medicare and Medicaid, as defined under the Social Security Act) and the Federal Employees Health Benefits Program (under U.S. Code Title 5) cannot impose the same restrictions. This includes states or entities administering these programs.
- Effective Date: For private plans, changes apply to plan years starting on or after January 1, 2026.
Significant Changes to Existing Law
- This legislation introduces a complete ban on these common cost-control tools, which are currently allowed under federal laws like the Public Health Service Act and Social Security Act to manage healthcare spending and prevent overuse.
- It shifts authority from insurers and program administrators to healthcare providers, removing federal permission for these practices in both private and public sectors— a major departure from the status quo where such reviews are routine to ensure efficient use of resources.
Potential Impacts
- On Citizens (Patients): Could speed up access to needed treatments by eliminating delays from approvals, potentially improving health outcomes and reducing administrative burdens on patients and doctors.
- On Government Agencies: Federal programs like Medicare and Medicaid may face higher costs without these controls, requiring budget adjustments or increased funding; agencies administering these (e.g., Centers for Medicare & Medicaid Services) would need to revise operations and oversight.
- On Health Insurers: Private companies might see rising premiums or costs as they lose tools to limit unnecessary care, possibly leading to broader industry changes in pricing and coverage.
- On International Relations: No direct impacts, as the bill focuses on domestic U.S. health policy.
Main Stakeholders Affected
- Patients and Healthcare Providers: Primary beneficiaries, gaining quicker access to care without insurer interference.
- Health Insurance Issuers and Group Health Plans: Directly restricted, affecting their ability to manage expenses.
- Federal and State Governments: Oversee programs like Medicare, Medicaid, and federal employee benefits; states implementing Medicaid would need to comply.
- Employers: Sponsors of group plans, potentially facing higher insurance costs.
Notable Legal, Constitutional, or Political Implications
- Legal: Could lead to challenges over enforcement, as it amends multiple statutes and applies broadly to "any" covered service, potentially conflicting with state laws or existing contracts; courts might review if it oversteps federal authority in regulating private insurance.
- Constitutional: Raises questions about federal preemption of state regulations on health plans, but aligns with Congress's commerce clause powers over interstate insurance markets.
- Political: Represents a push to reduce bureaucracy in healthcare, favoring provider autonomy over cost controls; it may spark debates on balancing patient rights with fiscal responsibility, influencing future reforms in areas like drug pricing or telehealth.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Rep. Van Drew, Jefferson [R-NJ-2]
Recent Actions
- 2025-01-22: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-01-22: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-01-22: Introduced in House
- 2025-01-22: Introduced in House
Bill Versions
- Doctor Knows Best Act of 2025 — issued 2025-01-22 — PDF (3 pages)